NeueHealth, Inc.
NEUE
$6.73
$0.010.15%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 18.68% | 35.52% | 46.92% | 94.45% | 282.53% |
| Total Other Revenue | -28.19% | -18.37% | -7.62% | 16.19% | 35.64% |
| Total Revenue | -19.31% | -9.01% | 1.35% | 26.91% | 54.53% |
| Cost of Revenue | -25.53% | -11.82% | 0.92% | 25.51% | 50.32% |
| Gross Profit | 18.45% | 7.01% | 3.66% | 35.11% | 86.21% |
| SG&A Expenses | -13.85% | -19.90% | -8.21% | -10.57% | -11.34% |
| Depreciation & Amortization | -14.48% | -18.42% | -31.99% | -38.24% | -23.73% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -22.62% | -14.03% | -2.23% | 12.92% | 27.63% |
| Operating Income | 45.44% | 42.37% | 21.28% | 38.27% | 42.01% |
| Income Before Tax | 84.19% | 82.33% | -103.63% | -76.72% | -64.89% |
| Income Tax Expenses | 281.86% | 131.07% | 85.10% | 59.98% | -138.97% |
| Earnings from Continuing Operations | 83.74% | 81.16% | -109.72% | -78.89% | -62.95% |
| Earnings from Discontinued Operations | 100.37% | 45.86% | 45.82% | 48.37% | 34.53% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -130.57% | 257.74% | 250.25% | 224.89% | 219.54% |
| Net Income | 88.30% | 77.26% | 26.33% | 30.86% | 20.89% |
| EBIT | 45.44% | 42.37% | 21.28% | 38.27% | 42.01% |
| EBITDA | 47.14% | 41.81% | 12.84% | 36.53% | 39.85% |
| EPS Basic | 85.00% | 75.29% | 26.16% | 30.43% | 20.69% |
| Normalized Basic EPS | -341.90% | 142.87% | 106.62% | 95.57% | 91.92% |
| EPS Diluted | 85.00% | 75.29% | 26.16% | 30.43% | 20.69% |
| Normalized Diluted EPS | -341.90% | 142.87% | 106.62% | 95.57% | 91.92% |
| Average Basic Shares Outstanding | 3.31% | 2.78% | 2.16% | 1.55% | 1.07% |
| Average Diluted Shares Outstanding | 3.31% | 2.78% | 2.16% | 1.55% | 1.07% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |